Latest News
MRK Holdings Inc.
- MRK: Positive Phase 3 results for sac-TMT and intismeran underpin a broad oncology pipeline
- MRK Holdings, Inc. Estimates – TSE:9980
- Merck & Co Inc Stock (MRK) Moved Down by 3.28% on Oct 22: A Full Analysis
- MRK Q3'26 Earnings: revenue estimate is 17.31B USD
- Merck Stock Forecast: MRK Bounces Off 50-Day EMA as ESMO Data and Q3 Earnings Near
- Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send?
- Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings
- Merck & Co. (NYSE:MRK): A Quality Investing Case With Strong ROIC but Revenue Growth Concerns
- Key facts: Merck (MRK) SAC‑TMT improves survival; Oct 26 webcast
- Merck & Co Inc Stock (MRK) Moved Up by 3.73% on Oct 14: A Full Analysis
- Merck & Co Inc Stock (MRK) Moved Down by 3.04% on Oct 5: What Investors Need To Know
- FDA Decision Watch: RHHBY, VTRS And IRD Face Key October Drug Rulings As MRK Withdraws Application
Headlines from the last 30 days, linking to the original publishers. See all market news →